Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
CEO and Fund Manager, Renaissance Venture Capital Fund
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Managing Director, D.E. Shaw and Co., L.P.
|Novalar Plans Shutdown Following Sale of OraVerse to Septodont||Bruce V. Bigelow||03/22/11||San Diego|
|Now What? Novalar Sells Its Anesthesia Reversal Drug to Septodont||Bruce V. Bigelow||03/21/11||San Diego|
|Page 1 of 1|